22nd Century Group (XXII)
Manufactures tobacco products for brands and develops FDA-authorized reduced-nicotine cigarettes.
Something off on this page? Send us feedback.
Produces cigarettes and filtered cigars for third-party brands while selling reduced-nicotine VLN and SPECTRUM research cigarettes. Most revenue comes from contract manufacturing at a single federally licensed U.S. facility, supported by nicotine-control tobacco-plant technology.
Manufactures cigarettes, filtered cigars, and other tobacco products for customer brands, while selling reduced-nicotine VLN cigarettes and SPECTRUM research cigarettes. NASCO runs an automated Mocksville facility, using conventional leaf sourced through third parties and reduced-nicotine leaf from contracted U.S. growers. Sales are primarily to U.S. customers, though contract manufacturing is offered to domestic and international partners.
Generates most revenue from contract-manufacturing agreements, with unit-based pricing and revenue recognized as products are made. Its nicotine-control technology combines licensed and owned tobacco-plant intellectual property, genetic engineering, gene editing, and plant breeding. VLN King and VLN Menthol King hold FDA modified-risk marketing orders with renewal applications under scientific review. The single leased plant supports both proprietary and contract-manufacturing revenue.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
No analyst notes in the last 24 months.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $6.1M · Total debt $1.3M · Total assets $26.2M · Shareholders' equity $18.6M
- Revenue
- $2.9M
- Operating income
- −$3.3M
- Net income
- −$3.3M
No dividends on record.
| Institutions | 0.00% | 7 shares | |
|---|---|---|---|
| 3 holders · as of Jun 30, 2026 | |||
| Insiders | 20.08% | 143.4K shares | |
| 11 holders · as of Aug 20, 2026 | |||
| Strategic holders | 0.00% | 5 shares | |
| 1 holder · as of Feb 14, 2025 | |||
| Other | 79.92% | 570.6K shares | |
| remainder | |||
714.0K company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (714.0K in the company's Sep 22, 2026 report, 345.1K elsewhere); stakes use the report.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Jonathan SchechterInsider | 9.98% | 71,256 | filed Aug 20, 2026 |
Joseph RedaInsider | 9.98% | 71,256 | filed Aug 20, 2026 |
Lawrence FirestoneInsiderdirector, officer: Chief Executive Officer | 0.03% | 227 | filed Nov 13, 2025 |
Daniel A. OttoInsiderofficer: Chief Financial Officer | 0.02% | 126 | filed Nov 13, 2025 |
Jonathan StaffeldtInsiderofficer: VP and Deputy General Counsel | 0.02% | 126 | filed Nov 13, 2025 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- Altria Group
Largest U.S. combustible rival across cigarettes and filtered cigars.
- British American Tobacco (ADR)
U.S. cigarette and tobacco incumbent through Reynolds American.
- Philip Morris International
International cigarette and smoke-free nicotine competitor.
- Perrigo
Store-brand nicotine replacement for adults trying to quit smoking.
- Pfizer
CHANTIX prescription therapy for adults seeking to quit smoking.
- Haleon (ADR)
U.S. nicotine-replacement portfolio for adults trying to quit smoking.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| 22nd Century Group | $1.82 | +2.82% | $610.9K | — | — | 0.1 | −29.9% |
| Altria Group | $68.69 | +0.23% | $114.44B | 14.5 | 11.9 | 5.2 | +1.3% |
| British American Tobacco (ADR) | $55.68 | −0.12% | $120.25B | 14.3 | — | 3.5 | −0.1% |
| Philip Morris International | $190.07 | +1.38% | $292.21B | 26.9 | 21.7 | 6.9 | +10.4% |
| Perrigo | $14.28 | +1.03% | $1.96B | — | 6.0 | 0.5 | −3.2% |
| Pfizer | $27.84 | +0.34% | $158.10B | 36.7 | 9.9 | 2.5 | +2.6% |
| Haleon (ADR) | $9.28 | −0.83% | $41.22B | 19.5 | — | 2.8 | +3.7% |
| Median | 19.5 | 10.9 | 3.1 | +1.9% |